Table 2.
Placebo-treated group (n = 25) | Ashwagandha-treated group (n = 21) | |||||
---|---|---|---|---|---|---|
Day 0 | Day 60 | Day 90 | Day 0 | Day 60 | Day 90 | |
Sperm concentration (×106/mL) | 10.24 ± 2.82 | 12.42 ± 4.75 | 13.23 ± 7.74 | 9.59 ± 4.37 | 18.8 ± 5.7# | 25.61 ± 8.6# |
Semen volume (mL) | 1.88 ± 0.65 | 2.3 ± 0.58 | 2.25 ± 0.41 | 1.74 ± 0.58 | 2.56 ± 0.7* | 2.76 ± 0.6# |
Sperm motility (%) | 18.6 ± 5.41 | 18.87 ± 5.86 | 20.27 ± 5.97 | 18.62 ± 6.11 | 26.04 ± 5.6# | 29.19 ± 6.31# |
Serum testosterone ng/mL | 4.42 ± 1.50 | — | 4.59 ± 1.48 | 4.45 ± 1.41 | — | 5.22 ± 1.39 |
Serum LH mIU/mL | 4.02 ± 1.20 | — | 4.35 ± 1.28 | 3.97 ± 1.21 | — | 5.31 ± 1.33 |
*P < 0.05, # P < 0.0001 as compared to the baseline values on Day 0 of the study duration (12 weeks). Values are expressed as mean ± SD.